Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
How Will Our Practice Change After the CLEAR Outcomes Trial?
Curr Atheroscler Rep
(Unknown)
Published: 2024
Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes.
Curr Atheroscler Rep
(Unknown)
Published: 2023
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.
Curr Atheroscler Rep
(Unknown)
Published: 2023
Natural Sirtuin1 Activators and Atherosclerosis: an Overview.
Curr Atheroscler Rep
(Unknown)
Published: 2023
Updates in Small Interfering RNA for the Treatment of Dyslipidemias.
Curr Atheroscler Rep
(Unknown)
Published: 2023
Updates in Drug Treatment of Severe Hypertriglyceridemia.
Curr Atheroscler Rep
(Unknown)
Published: 2023
Statin Intolerance: an Overview of US and International Guidance.
Curr Atheroscler Rep
(Unknown)
Published: 2023